Nurix Therapeutics, Inc. (NRIX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$264.46M | -36.6% |
| 2024 | -$193.57M | -34.5% |
| 2023 | -$143.95M | +20.2% |
| 2022 | -$180.36M | -53.9% |
| 2021 | -$117.19M | -171.0% |
| 2020 | -$43.24M | -99.3% |
| 2019 | -$21.70M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$264.46M | -36.6% |
| 2024 | -$193.57M | -34.5% |
| 2023 | -$143.95M | +20.2% |
| 2022 | -$180.36M | -53.9% |
| 2021 | -$117.19M | -171.0% |
| 2020 | -$43.24M | -99.3% |
| 2019 | -$21.70M | — |